Work

Abstract PS4-01-14: Evaluation of Metabolic Dysregulation, Endocrine Therapy Outcomes, and Tumor Biology in HER2-/HR+ Breast Cancer using a Multi-Omic, Real-World Analysis

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-01-14

Authors: J. Hundal, R. Plagens, A. Elliott, G. Sledge, C. Travaline, S. Graff, M. Lustberg, M. Vasekar, J. Leone

Institutions: Cleveland Clinic, Caris Life Sciences (United States), Pennsylvania State University, Penn State Cancer Institute, Brown University, Yale Cancer Center, Yale University, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129331333

Cites:

Cited by:

Related to: